Moleculin Biotech, Inc. - 8-K Filing
Moleculin Biotech notified by Nasdaq that its stock failed to meet the minimum bid price requirement for continued listing and is ineligible for a compliance period due to prior reverse split. (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing)
Tickers: $MBRX